- Health Topics
- The Science
- Grants and Training
- News and Events
- About NHLBI
Biography
Gary H. Gibbons, M.D., is Director of the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH), where he oversees the third largest institute at the NIH, with an annual budget of more than $3 billion and a staff of 917 federal employees.
The NHLBI provides global leadership for research, training, and education programs to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives.
Prior to being named director of the NHLBI, Gibbons served as a member of the National Heart, Lung, and Blood Advisory Council (NHLBAC) from 2009-2012. He was also a member of the NHLBI Board of Extramural Experts (BEE), a working group of the NHLBAC.
Before joining the NHLBI, Gibbons served as the founding director of the Cardiovascular Research Institute, chairperson of the Department of Physiology, and professor of physiology and medicine at the Morehouse School of Medicine, in Atlanta.
Under his leadership of the Cardiovascular Research Institute, Gibbons directed NIH-funded research in the fields of vascular biology, genomic medicine, and the pathogenesis of vascular diseases. During his tenure, the Cardiovascular Research Institute emerged as a center of excellence, leading the way in discoveries related to the cardiovascular health of minority populations. Gibbons received several patents for innovations derived from his research in the fields of vascular biology and the pathogenesis of vascular diseases.
Gibbons earned his undergraduate degree from Princeton University in Princeton, N.J., and graduated magna cum laude from Harvard Medical School in Boston. He completed his residency and cardiology fellowship at the Harvard-affiliated Brigham and Women's Hospital in Boston. Prior to joining the Morehouse School of Medicine in 1999, Gibbons was a member of the faculty at Stanford University in Stanford, Calif., from 1990-1996, and at Harvard Medical School from 1996-1999.
Throughout his career, Gibbons has received numerous honors, including election to the Institute of Medicine of the National Academies of Sciences; selection as a Robert Wood Johnson Foundation Minority Faculty Development Awardee; selection as a Pew Foundation Biomedical Scholar; and recognition as an Established Investigator of the American Heart Association (AHA).
Last month, NIH took important steps to ensure that diversity, equity, and inclusion become ingrained in biomedical research through the launch of the UNITE initiative.
Selected Publications
Association between depression and inflammation--differences by race and sex: the META-Health study.
Authors: Morris AA, Zhao L, Ahmed Y, Stoyanova N, De Staercke C, Hooper WC, Gibbons GH, Din-Dzietham R, Quyyumi A, Vaccarino V.
Psychosom Med
2011 Jul 01;73(6):462-8
Glomerular expression of kidney injury molecule-1 and podocytopenia in diabetic glomerulopathy.
Authors: Zhao X, Zhang Y, Li L, Mann D, Imig JD, Emmett N, Gibbons GH, Jin LM.
Am J Nephrol
2011 Jan 01;34(3):268-280
Effectiveness of an intervention to improve the documentation required for diagnosis of metabolic syndrome in clinics serving African-American patients.
Authors: Pan Q, Meng YX, Gibbons GH, Strayhorn G.
Qual Prim Care
2009 Jan 01;17(3):191-6
Association of C-reactive protein with surrogate measures of insulin resistance among nondiabetic US from National Health and Nutrition Examination Survey 1999-2002.
Authors: Meng YX, Ford ES, Li C, Quarshie A, Al-Mahmoud AM, Giles W, Gibbons GH, Strayhorn G.
Clin Chem
2007 Dec 01;53(12):2152-9
Geography and genography: prediction of continental origin using randomly selected single nucleotide polymorphisms.
Authors: Allocco DJ, Song Q, Gibbons GH, Ramoni MF, Kohane IS.
BMC Genomics
2007 Mar 10;8(68)
Awards
NHLBI Director Dr. Gary H. Gibbons was interviewed by Princeton University Alumni magazine for an Alumni Spotlight.
Dos líderes de los NIH llaman a sus comunidades a buscar de información verídica de fuentes confiables y promover la confianza en la ciencia para acabar con la COVID-19.
As the toll of illness and death from COVID-19 keeps rising across the country and continues to disproportionately affect racial and ethnic minorities, two NIH leaders are calling on their communities to get the facts and help build trust in science to turn the tide of the pandemic.